Newsroom | 40676 results

Sorted by: Latest

Medical Devices
-

Avvio Medical Establishes New Ureteral Stone Treatment Vertical at AUA 2026 Annual Meeting

SAN FRANCISCO--(BUSINESS WIRE)--Avvio Medical, a clinical-stage medical device company developing Microbubble SonoLithotripsy for the treatment of ureteral stones, reports today on its successful conference at the 2026 American Urological Association (AUA) Annual Meeting, held May 15-18 in Washington, DC. The company advanced its mission of making ureteral obstruction therapy local, immediate, safe, and free of routine use of stents and anesthesia. A Showcase Moment at the AUA Innovation Nexus...
-

InterSystems IntelliCare se convierte en el primer EHR nativo en inteligencia artificial en obtener la certificación del Reglamento de Dispositivos Médicos de la Unión Europea (EU MDR)

BOSTON--(BUSINESS WIRE)--InterSystems, proveedor de tecnología de datos creativa que impulsa más de mil millones de registros de salud a nivel mundial, anunció hoy que sus soluciones EHR (Electronic Health Record o registro clínico electrónico al español) fueron certificadas como software de dispositivo médico Clase IIa bajo el Reglamento de Dispositivos Médicos (MDR) de la Unión Europea, conforme al Reglamento (UE) 2017/745. Esta aprobación convierte al EHR completamente unificado y nativo en...
-

Thermo Fisher Scientific Announces Quarterly Dividend

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July 15, 2026, to shareholders of record as of June 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier...
-

Align Technology to Speak at Upcoming Financial Conferences

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. As noted below, the presentations will be webcast live via the Investor Relations section of Align Te...
-

CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced the company will participate in the following investor conferences: Jefferies 2026 Global Healthcare Conference at the Marriot Marquis in New York, NY. Presentation on Wednesday, June 3, 2026,...
-

Reflow Medical Reports Six-Month Results from DEEPER CORONARY Study of Spur® Elute Stent

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical announces six-month DEEPER CORONARY study results for the Spur® Elute Sirolimus-Eluting Retrievable Stent System at EuroPCR 2026....
-

Vyriad Launches G-Link: A Modular Platform Advancing T-Cell Targeted Lentiviral Vector Delivery for In Vivo and Ex Vivo Applications

ROCHESTER, Minn.--(BUSINESS WIRE)--G-Link is a first-in-class modular adaptor protein technology designed to enable and enhance T-cell-targeting delivery across CAR T workflows....
-

InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities

SCHLIEREN, Switzerland & SAN DIEGO--(BUSINESS WIRE)--InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier provider of high-content imaging and phenotypic assay technologies based in San Diego, California. The acquisition marks an important new chapter for PhenoVista Biosciences, enabling the company to significantly expand its scientific and commercial impact by c...
-

InterSystems IntelliCare wird das erste KI-native KIS mit Zertifizierung nach der EU-Medizinprodukteverordnung

BOSTON--(BUSINESS WIRE)--InterSystems, ein Anbieter kreativer Datentechnologien, dessen Lösungen weltweit mehr als eine Milliarde Gesundheitsakten unterstützen, gab heute bekannt, dass seine Krankenhausinformationssystem (KIS)-Lösungen als Medizinprodukte der Klasse IIa gemäß der Medizinprodukteverordnung (MDR) nach Verordnung (EU) 2017/745 zertifiziert wurden. Mit dieser Zulassung ist das erste vollständig integrierte KI-native KIS in der Europäischen Union nach MDR Klasse IIa zertifiziert. Di...
-

Jupiter Endovascular Announces Positive Results From SPIRARE II Pivotal Trial at EuroPCR 2026

MENLO PARK, Calif.--(BUSINESS WIRE)--Jupiter Endovascular announced positive results from its SPIRARE II pivotal trial at EuroPCR showing the trial met both of its primary endpoints....